|
NURSA tutorial provides a succinct overview
of nuclear receptor signaling for researchers and clinicians.
San Francisco, CA, and Houston, TX, December
8th, 2003—GeneEd, Inc., the leading provider of advanced
e-Learning solutions for the life science industry, today announced
that it has collaborated with Baylor College of Medicine (BCM) researchers
to develop a novel e-learning training program for NURSA, the Nuclear
Receptor Signaling Atlas web portal (http://www.nursa.org).
The NURSA web portal is being developed with the goal of providing
a single resource for the curation, management and dissemination
of validated experimental data in the field of nuclear receptor
research.
NURSA, a trans-NIH-funded team science project, consists of a consortium
of scientists from five institutions as well as representatives
from the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), the National Institute of Aging (NIA), and the
National Cancer Institute (NCI). GeneEd and the BCM researchers
collaborated to developed the content for the training program,
and then utilized GeneEd's proprietary Repurposing™ and Viewing™
engine technology to create compelling, intuitive and effective
e-learning that synthesizes and summarizes both historical and recent
developments in the field.
"The list of cloned and characterized nuclear receptors and
coregulators is substantial, representing an explosive accumulation
of information that is yet to be organized into a coherent picture
of the biological significance of these molecules," said Dr.
Neil McKenna of BCM, editor of the NURSA web portal. "The NURSA
e-Learning program enables researchers and clinicians to understand
current models of nuclear receptor signaling gathered together in
a single, validated location, and made available in a succinct,
easy-to-understand format."
"By utilizing our off-the-shelf learning objects in genomics,
proteomics, signaling and drug design, we were able to rapidly and
effectively create compelling e-learning lessons that fulfilled
the mission of the NURSA portal to provide a free-standing, interactive
multimedia tutorial to all visitors" said Dr. Salil D. Patel,
GeneEd's co-founder and Chief Scientific Officer. "Our validated,
multimedia learning object database enables us to combine text,
tables, charts, static and animated graphics and PubMed links into
a single coherent whole." Added Rosanna Der, Senior FLASH developer,
"Repurposing GeneEd learning objects with Baylor's editorial
content was fast and effective, allowing for rapid dissemination
of the product, thanks to the "knowledge object" strategy
pursued by both sides. The resultant course format provides for
both quizzes and interactivity."
All GeneEd catalog and custom courseware are Continuing Medical
Education (CME) Category One accredited and approved. GeneEd's courses
have been developed to allow simple technical integration onto a
Learning Management System (LMS), and all GeneEd E-Learning courses
are SCORM 1.2 compliant, and have been successfully integrated with
FDA-certified 21CFR11-compliant LMS applications.
About GeneEd
GeneEd, Inc. was founded in 1997 to provide life science and healthcare
e-learning solutions for the pharmaceutical, biotechnology, instrument
and medical device, and hospital/HMO industries. GeneEd's Life Science
industry customers include AstraZeneca, Pfizer, the ALZA division
of Johnson & Johnson, Celera, Bio-Rad, and IBM Life Sciences,
amongst many others. (http://www.geneed.com/clients/index.html)
GeneEd utilizes the best life science content, combined with advanced
e-learning development technology, to rapidly create basic and advanced
curricula in the areas of genomics, therapeutic area training (for
clinical research, product development, and sales and marketing
teams), computer assisted drug design, drug discovery and development,
pharmacogenomics and clinical genomics, bioinformatics and microarray
informatics, and therapeutic and diagnostic products. GeneEd, Inc.
is a privately held company headquartered in San Francisco, California.
Visit http://www.GeneEd.com
for additional information about GeneEd and its courseware.
About NURSA
The Nuclear Receptor Signaling Atlas (NURSA) comprises an integrated,
multidisciplinary effort to unravel the molecular, biochemical,
and physiological functions of orphan nuclear receptors (ONRs),
and ultimately of all nuclear receptors. Its long-term goal is to
delineate the role(s) of ONRs in normal and pathophysiological conditions,
including obesity, osteoporosis, hormone dependent cancers, processes
of aging, and diabetes and its complications. The objective of NURSA
is to provide useful data to the community in a timely fashion for
use in their own investigations relevant to ONRs. Visit NURSA at
http://www.nursa.org.
The primary directive of the NURSA program is to gather and organize
information relating to key aspects of orphan nuclear receptor biology,
with the aim of extending this blueprint to the wider discipline
of nuclear receptor signaling. Commensurate with this directive,
NURSA's goals can be distilled into two broad aims: (i) to execute
research strategies designed to rapidly and efficiently elucidate
those facets of orphan nuclear receptor biology deemed most critical
to its understanding; and (ii) to facilitate the generation of hypotheses,
design of experiments and communication of results by scientists
active in the field.
|
